Cscec Scimee Sci.&Tech. Co.,Ltd (300425.SZ)
CNY 4.95
(1.02%)
CNY 4.95
(1.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 107.55 Million | 17.71 Million | 181.92 Million | 221.1 Million | 155.51 Million | -80.51 Million |
| Net Income | 179.48 Million | 198.72 Million | 184.06 Million | 173.75 Million | 165.69 Million | 145.54 Million |
| Depreciation & Amortization | 99.92 Million | 96.09 Million | 74.36 Million | 61.26 Million | 59.8 Million | 58.87 Million |
| Deferred income taxes | -11.74 Million | -11.28 Million | 2.05 Million | -7.12 Million | -1.88 Million | -1.01 Million |
| Stock-based compensation | 12.13 Million | 5.88 Million | - | - | - | - |
| Change in working capital | -294.21 Million | -418.61 Million | -163.12 Million | -102.47 Million | -157.44 Million | -384.4 Million |
| Other non-cash items | 73.16 Million | 141.52 Million | 86.62 Million | 88.56 Million | 87.45 Million | 99.47 Million |
| Investing Cash Flow | -164.9 Million | -148.66 Million | -246.56 Million | -193.57 Million | -29.08 Million | -191.46 Million |
| Investments in PPE | -169.94 Million | -189.06 Million | -247.98 Million | -179.55 Million | -44.44 Million | -120.42 Million |
| Acquisitions | 1.46 Million | 22.11 Million | 6.14 Million | 1.03 Million | 18.77 Million | -96.66 Thousand |
| Investment purchases | - | -22.11 Million | -6.14 Million | -3.14 Million | -18.77 Million | -70.98 Million |
| Sales/Maturities of investments | 4.43 Million | 18.28 Million | 895.6 Thousand | 3.35 Million | 259.7 Thousand | 120.46 Million |
| Other Investing Activities | 5.03 Million | 22.11 Million | 527.62 Thousand | -15.26 Million | 15.09 Million | -120.42 Million |
| Financing Cash Flow | -82.18 Million | 35.02 Million | 64.7 Million | -35.33 Million | -158.63 Million | 244.37 Million |
| Debt repayment | -13.21 Million | -602.13 Million | -480.84 Million | -479.16 Million | -705.73 Million | -310.9 Million |
| Dividends payments | -38.51 Million | -65.46 Million | -33.78 Million | -33.79 Million | -33.83 Million | -109.97 Million |
| Common Stock Repurchased | - | - | - | -518.04 Thousand | - | -2.11 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -28.35 Million | 702.63 Million | 605.38 Million | 501.41 Million | 614 Million | 665.25 Million |
| Accounts receivables | -414.85 Million | -514.79 Million | -96.16 Million | -124.81 Million | -203.46 Million | -400.13 Million |
| Accounts payables | 127.96 Million | 73.01 Million | -10.84 Million | -13.42 Million | 10.11 Million | 116.98 Million |
| Inventory | 4.41 Million | 34.44 Million | -58.16 Million | 42.89 Million | 37.79 Million | -100.23 Million |
| Other working capital | 6.14 Million | -11.28 Million | 2.05 Million | -7.12 Million | -1.88 Million | -284.16 Million |
| Cash at beginning of period | 226.47 Million | 322.39 Million | 322.37 Million | 330.39 Million | 362.37 Million | 389.27 Million |
| Cash at end of period | 86.91 Million | 226.47 Million | 322.39 Million | 322.37 Million | 330.39 Million | 362.37 Million |
| Capital Expenditure | -169.94 Million | -189.06 Million | -247.98 Million | -179.55 Million | -44.44 Million | -120.42 Million |
| Effect of forex changes on cash | -13.18 Thousand | -3388.15 | -44.81 Thousand | -216.85 Thousand | 239.39 Thousand | 709.07 Thousand |
| Net cash flow / Change in cash | -139.55 Million | -95.92 Million | 19.69 Thousand | -8.02 Million | -31.97 Million | -26.89 Million |
| Free Cash Flow | -62.39 Million | -171.34 Million | -66.06 Million | 41.55 Million | 111.06 Million | -200.93 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.09 Million | 22.43 Million | 3.07 Million | 122.16 Million | 179.48 Million | -2.95 Million |
| Depreciation & Amortization | - | 37.66 Million | 37.66 Million | 99.92 Million | 99.92 Million | -50.06 Million |
| Deferred income taxes | - | - | - | - | -11.74 Million | 33.27 Million |
| Stock-based compensation | - | 3.4 Million | - | 12.13 Million | 12.13 Million | -5.7 Million |
| Change in working capital | - | 23.88 Million | - | -404.28 Million | -294.21 Million | 22.49 Million |
| Other non-cash items | 19.54 Million | 62.37 Million | 31.54 Million | 218.82 Million | 73.16 Million | -2.29 Million |
| Investing Cash Flow | -2.3 Million | -4.86 Million | -30.49 Million | -98.28 Million | -164.9 Million | -24.36 Million |
| Investments in PPE | -2.29 Million | -5.05 Million | -30.57 Million | -98.58 Million | -169.94 Million | -28.79 Million |
| Acquisitions | 21.35 Thousand | 6802.32 | 83.06 Thousand | 292.49 Thousand | 1.46 Million | 3.19 Million |
| Investment purchases | - | - | - | - | - | -4.38 Million |
| Sales/Maturities of investments | -26.53 Thousand | 180.81 Thousand | - | - | 4.43 Million | 1.18 Million |
| Other Investing Activities | - | 188.1 Thousand | 83.06 Thousand | 292.49 Thousand | 5.03 Million | 4.43 Million |
| Financing Cash Flow | -154.61 Million | 42.1 Million | 16.54 Million | -29.24 Million | -82.18 Million | -18.47 Million |
| Debt repayment | -87.5 Million | -37.81 Million | -29.5 Million | -15.87 Million | -13.21 Million | -180.5 Million |
| Dividends payments | - | -7.51 Million | -6.24 Million | -38.51 Million | -38.51 Million | -7.14 Million |
| Common Stock Repurchased | - | - | - | - | - | -854.65 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -67.11 Million | 17.16 Million | -12.95 Million | -6.32 Million | -28.35 Million | 169.16 Million |
| Accounts receivables | - | 6.39 Million | - | -414.85 Million | -414.85 Million | -26.49 Million |
| Accounts payables | - | - | - | - | 127.96 Million | - |
| Inventory | - | 14.08 Million | - | 4.41 Million | 4.41 Million | 54.69 Million |
| Other working capital | - | 3.4 Million | - | 6.14 Million | 6.14 Million | -5.7 Million |
| Cash at beginning of period | 199.57 Million | 112.77 Million | 192.74 Million | 177.84 Million | 226.47 Million | 229.17 Million |
| Cash at end of period | 103.61 Million | 199.57 Million | 112.77 Million | 86.91 Million | 86.91 Million | 177.84 Million |
| Capital Expenditure | -2.29 Million | -5.05 Million | -30.57 Million | -98.58 Million | -169.94 Million | -28.79 Million |
| Effect of forex changes on cash | - | 57.88 Thousand | 27.27 Thousand | -27.27 Thousand | -13.18 Thousand | 16.5 Thousand |
| Net cash flow / Change in cash | -95.96 Million | 86.8 Million | -79.97 Million | -90.92 Million | -139.55 Million | -51.32 Million |
| Free Cash Flow | 15.15 Million | 42.1 Million | 4.04 Million | -61.95 Million | -62.39 Million | -34.04 Million |
SYNGENE
SSOF
ACHR-WT
CSNVF
688639
CGEN